Anthocyanins attenuate body weight gain via modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus

Neuropeptides

Volumn 47, Issue 5, 2013, Pages 347-353

  Badshah, Haroon ^a   Ullah, Ikram ^a   Kim, So Eun ^a   Kim, Tae hyun ^a   Lee, Hae Young ^a   Kim, Myeong Ok ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Anthocyanins; GABAB1 receptor; Neuropeptide Y; Obesity; P CREB; PKA

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B1 RECEPTOR; ANTHOCYANIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ALPHA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FOOD INTAKE; HYPOTHALAMUS; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SOYBEAN; SPRAGUE DAWLEY RAT; WEIGHT GAIN; WESTERN BLOTTING;

GLYCINE MAX; RATTUS;

ANTHOCYANINS; GABA(B1) RECEPTOR; NEUROPEPTIDE Y; OBESITY; P-CREB; PKA;

ADIPOSE TISSUE; ANIMALS; ANTHOCYANINS; CEREBRAL CORTEX; DIET; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; WEIGHT GAIN;

EID: 84886951607     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.06.001     Document Type: Article

References (51)

1. Arima H., Oiso Y. Positive effect of baclofen on body weight reduction in obese subjects: a pilot study. Intern. Med. 2010, 49:2043-2047.
2. Barness L.A., Opitz J.M., Barness E.G. Obesity: genetic, molecular, and environmental aspects. Am. J. Med. Genet. A 2007, 143:3016-3034.
3. Bi S., Kim Y.J., Zheng F. Dorsomedial hypothalamic NPY and energy balance control. Neuropeptides 2012, 46:309-314.
4. Berthoud H.R., Sutton G.M., Townsend R.L., Patterson L.M., Zheng H. Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size. Physiol. Behav. 2006, 89:517-524.
5. Burdakov D., Liss B., Ashcroft F.M. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J. Neurosci. 2003, 23:4951-4957.
6. Calza L., Giardino L., Battistini N., Zanni M., Galetti S., Protopapa F., Velardo A. Increase of neuropeptide Y-like immunoreactivity in the paraventricular nucleus of fasting rats. Neurosci. Lett. 1989, 104:99-104.
7. Carroll K.K., Kurowska E.M. Soy consumption and cholesterol reduction: review of animal and human studies. J. Nutr. 1995, 125:594-597.
8. Choung M.G., Baek I.Y., Kang S.T., Han W.Y., Shin D.C., Moon H.P., Kang K.H. Isolation and determination of anthocyanins in seed coats of black soybean. J. Agric. Food Chem. 2001, 49:5848-5851.
9. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115:427-429.
10. Dube M.G., Sahu A., Kalra P.S., Kalra S.P. Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 1992, 131:684-688.
11. Fetissov S., Nicolaidis S. Neuropeptide Y in the magnocellular hypothalamic neurons of obese Zuker rats. Neuropeptides 1998, 32:63-66.
12. Gehlert D.R., Thompson L.K., Hemrick-Luecke S.K., Shaw J. Monoaminergic compensation in the neuropeptide Y deficient mouse brain. Neuropeptides 2008, 42:367-375.
13. Harborne J.B., Grayer R.J. The anthocyanins. The Flavonoids: Advances in Research Since 1980 1980, 1-20. Chapman and Hall, London. J.B. Harborne (Ed.).
14. He J., Giusti M.M. Anthocyanins: natural colorants with health-promoting properties. Ann. Rev. Food Sci. Technol. 2009, 1:163-187.
15. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Neurobiology 1991, 88:10931-10935.
16. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 1999, 20:68-100.
17. Kalra S.P., Kalra P.S. Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2003, 22:49-55.
18. Kim Y.M., Jin Y.J., Rheel Y., Cha B.S., Lee H.C., Lim S.K. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732. J. Mol. Endocrinol. 2007, 38:455-465.
19. Kim H.J., Tsoy I., Park J.M., Chung J.I., Shin S.C., Chang K.C. Anthocyanins from soybean seed coat inhibit the expression of TNF-α-induced genes associated with ischemia/reperfusion in endothelial cell by NF-κB-dependent pathway and reduce rat myocardial damages incurred by ischemia and reperfusion in vivo. FEBS Lett. 2006, 580:1391-1397.
20. Kim H.J., Kim J.N., Han S.N., Nam J.H., Na H.N., Ha T.J. Black soybean anthocyanins inhibit adipocytes differentiation in 3T3-L1 cells. Nutr. Res. 2012, 32:770-771.
21. Ko M.K., Kwon T.W., Song Y.S. Effect of yellow and black soybean on plasma and hepatic lipid composition and fecal lipid extraction in rats. J. Korean. Soc. Food Sci. Nutr. 1998, 27:126-131.
22. Kwon S.H., Ahn I.S., Kim S.O., Kong C.S., Chung H.Y., Do M.S., Park K.Y. Anti-obesity and hypolipidemic effects of black soybean anthocyanins. J. Med. Food 2007, 10:552-556.
23. Lin E.-J.D., Sainsbury A., Lee N.J., Boey D., Couzens M., Enrequez R., Slack K., Bland R., During M.J., Herzog H. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptideY overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology 2006, 147:5094-5101.
24. McCormick D.A. GABA as an inhibitory neurotransmitter in human cerebral cortex. J. Neurophysiol. 1989, 62:1018-1027.
25. McKibbin P.E., Cotton S.J., McMillan S., Holloway B., Mayers R., McCarthy H.D., Williams G. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats: possible relationship to obesity and neuroendocrine disturbances. Diabetes 1991, 40:1423-1429.
26. Mortensen A. Carotenoids and other pigments as natural colorants. Pure Appl. Chem. 2006, 78:1477-1491.
27. Oyama L.M., do Nascimento C.M., Carnier J., de Piano A., Tock L., Sanches Pde L., Gomes F.A., Tufik S., de Mello M.T., Damaso A.R. The role of anorexigenic and orexigenic neuropeptides and peripheral signals on quartiles of weight loss in obese adolescents. Neuropeptides 2010, 44(1):467-474.
28. Pinard A., Seddik R., Bettler B. GABAB receptors: physiological functions and mechanisms of diversity. Adv. Pharmacol. 2010, 58:231-255.
29. Pu, S., Jain, M., Horvath, T.L., Diano, S., Kalra, S.P., Co-existence of neuropeptide Y (NPY) and g-aminobutyric acid (GABA) in the hypothalamus: interactive effects on feeding. In: Program of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 23, 1344, 1997.
30. Pu S., Jain M.R., Horvath T.L., Diano S., Kalra P.S., Kalra S.P. Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 1999, 140:933-940.
31. Rosmaninho-Salgado J., Cortez V., Estrada M., Santana M.M., Gonçalves A., Marques A.P., Cavadas C. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes. Neuropeptides 2012, 46:359-366.
32. Rechner A.R., Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res. 2005, 116:327-334.
33. Redman L.M., Ravussin E. Energy expenditure in obesity. Contemporary Endocrinology: Treatment of the Obese Patient 2007, 158. Humana Press, Totowa, NJ. R.F. Kushner, D.H. Bessesen (Eds.).
34. Reisin E., Jack A.V. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med. Clin. North Am. 2009, 93:733-751.
35. Sahu A., Kalra P.S., Kalra S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 1988, 9:83-86.
36. Sainsbury A., Rohner-Jeanrenaud F., Cusin I., Zakrzewska K.E., Halban P.A., Gaillard R.C., Jeanrenaud B. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinemia. Diabetologia 1997, 40:1269-1277.
37. Sato I., Arima H., Ozaki N., Watanabe M., Goto M., Hayashi M., Banno R., Nagasaki H., Oiso Y. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J. Neurosci. 2005, 25:8657-8664.
38. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
39. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
40. Sousa-Ferreira L., Garrido M., Nascimento-Ferreira I., Nobrega C., Santos-Carvalho A., Alvaro A.R., Rosmaninho-Salgado J., Kaster M., Kügler S., de Almeida L.P., Cavadas C. Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats. PLoS One 2011, 6:e22333.
41. Szekely M., Petervari E., Pakai E., Hummel Z., Szelnyl Z. Acute, subacute and chronic effects of central neuropeptide Y on energy balance in rats. Neuropeptides 2005, 39:103-115.
42. Szekely M., Szelenyi Z. Regulation of energy balance by peptides: a review. Curr. Protien Pept. Sci. 2005, 6:327-353.
43. Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Dietary cyanidin 3-O-beta-d-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr. 2003, 133:2125-2130.
44. Wild S.H., Byrne C.D. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ 2006, 333:1009-1011.
45. Wilding J.P., Gilbey G., Bailey C.J., Batt R.A., Williams G., Ghatei M.A., Bloom S.R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993, 132:1939-1944.
46. Wilding J.P.H. Neuropeptides and appetite control. Diabet. Med. 2002, 19:619-627.
47. Williams G., Shellard L., Lewis D.E., McCarthy H.D., Koeslag D.G., Russell J.C. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat. Peptides 1992, 13:537-540.
48. Yokosuka M., Xu B., Pu S., Kalra P.S., Kalra S.P. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol. Behav. 1998, 64:331-338.
49. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993, 133:1753-1758.
50. Zhang Z.U., Wang M.W. Obesity, a health burden of a global nature. Acta Pharmacol. Sin. 2011, 185:145-147.
51. Zhu W., Jia Q., Wang Y., Zhang Y., Xia M. The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway. Free Radic. Biol. Med. 2012, 52:314-327.